Faeth Therapeutics (FTH) Interest & Investment Income (2021 - 2026)
Faeth Therapeutics' (FTH) quarterly Interest & Investment Income came in at $392000.0 in Q1 2026, little changed YoY from $392000.0 in Q1 2025, and up 75.78% on a QoQ basis from $223000.0 in Q4 2025.
Faeth Therapeutics (FTH) Interest & Investment Income (2021 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 6 years of Interest & Investment Income data on file, last reported at $392000.0 in Q1 2026.
- Quarterly Interest & Investment Income changed 0.0% year-over-year to $392000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $618000.0 (down 78.47% YoY) and the FY2025 annual result came in at $1.2 million, down 51.41% from the prior year.
- Interest & Investment Income improved to $392000.0 in Q1 2026, from $223000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q4 2023 to a low of -$566000.0 in Q1 2022.
- A 5-year average of $407117.6 and a median of $147000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income plunged 209.9% — and 2023, when it surged 2000.0%.
- Tracing FTH's Interest & Investment Income over 5 years: stood at $609000.0 in 2022, then surged by 396.22% to $3.0 million in 2023, then declined by 23.0% to $2.3 million in 2024, then tumbled by 90.42% to $223000.0 in 2025, then jumped by 75.78% to $392000.0 in 2026.
- The last three Interest & Investment Income figures came in at $392000.0 (Q1 2026), $223000.0 (Q4 2025), and $8000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.26 Mn |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 223,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | -5,000.00 |
| Mar 31, 2025 | 392,000.00 |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | 147,000.00 |
| Jun 30, 2023 | 274,000.00 |
| Mar 31, 2023 | 181,000.00 |
| Dec 31, 2022 | 609,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | -313,000.00 |
| Mar 31, 2022 | -566,000.00 |
| Dec 31, 2021 | 869,000.00 |
| Sep 30, 2021 | 278,000.00 |